CD274 and anemia: Petrelli et al. performed a systematic review and meta-analysis of forty-seven trials including 9,324 patients with solid tumors treated with PD-L1 inhibitor monotherapy or in combination immunotherapy for incidence of hematologic irAEs; however, this study primarily focused on anemia.